/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-03-20-10-09-17-602-641830cdf636ea193857048d.jpg)
A much-awaited extension of the MDR transition period became effective today with the publication of Regulation (EU) 2023/607 in the...
Cortex - Life Sciences Insights
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-02-06-09-38-23-645-63e0ca8ff636e91420348d60.jpg)
On 31 January 2023CTIS) established by Regulation (EU) 536/2014 on clinical trials (CTR) became mandatory. In a nutshell, pharmaceutical...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/5ed622ef8cb62a041c7fddf8/2022-10-19-13-31-55-393-634ffc4bf636e904f8b0af32.PNG)
Our EU Life Sciences Regulatory team led by Marco de Morpurgo and Nicola Landolfi have produced a guide on EU Pharma & Medical Device...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-07-14-16-39-42-450-62d046cef636e918b0ab7d3b.jpg)
TodayRegulation on standards of quality and safety for substances of human origin intended for human application (Proposal). The...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/612f875dfac91e13ac7ca0dd/2022-03-04-14-18-15-709-62221fa7f636e910dcb63426.jpg)
In a note published on 2 March 2022, the Italian Medicines Agency (AIFA) confirmed that all pharmaceutical companies must, by no later...
Following an informal heads-up on 25 March 2020, today the European Commission adopted a proposed regulation to postpone by one year the...
On 1 January 2021, important transparency obligations provided for in the Code of Ethics of Confindustria Dispositivi Medici (the Italian...
